Immune Cell Entry to Central Nervous System - Current Understanding and Prospective Therapeutic Targets

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|9|4|315-327

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.9, Iss.4, 2009-12, pp. : 315-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Blood-Central Nervous System Barriers Actively Control Immune Cell Entry into the Central Nervous System

By  

Current Pharmaceutical Design, Vol. 14, Iss. 16, 2008-06 ,pp. : 1555-1565

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines in the Central Nervous System: Targets for Therapeutic Intervention

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 4, 2004-08 ,pp. : 271-280

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondria as Therapeutic Targets of Estrogen Action in the Central Nervous System

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 4, 2004-08 ,pp. : 297-313

Bentham Science Publishers

Access to resources Recommend Favorite

Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System

By  

Current Neuropharmacology, Vol. 11, Iss. 2, 2013-01 ,pp. : 197-208

Bentham Science Publishers

Access to resources Recommend Favorite

Animal Models of Central Nervous System Immune-Mediated Diseases: Therapeutic Interventions with Bioactive Peptides and Mimetics

By  

Current Medicinal Chemistry, Vol. 12, Iss. 13, 2005-06 ,pp. : 1513-1519

Bentham Science Publishers

Access to resources Recommend Favorite